Atlas Trials

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Clinical trial NCT04015518 · COMPLETED

Trial details

NCT number
NCT04015518
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Palmoplantar Pustulosis (PPP)
Start date
2019-07-31
Primary completion
2020-08-06
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.